These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22166878)

  • 41. [Mass screening and early detection of cancer: organizational characteristics of preventive services in Italy].
    Federici A; Mangia M; Giorgi Rossi P
    Ann Ig; 2009; 21(5):489-500. PubMed ID: 20058539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for the major malignancies affecting women: current guidelines.
    Paley PJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):1021-30. PubMed ID: 11303215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recommendations on cancer screening in the European Union. Advisory Committee on Cancer Prevention].
    Lynge E
    Ugeskr Laeger; 2002 Jan; 164(2):176-8. PubMed ID: 11831084
    [No Abstract]   [Full Text] [Related]  

  • 46. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention.
    Eur J Cancer; 2000 Aug; 36(12):1473-8. PubMed ID: 10930794
    [No Abstract]   [Full Text] [Related]  

  • 47. Update on breast and cervical cancers.
    Johnson CL
    AWHONN Lifelines; 2000; 4(1):20-1. PubMed ID: 11033612
    [No Abstract]   [Full Text] [Related]  

  • 48. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Responsible cancer screening].
    Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
    Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
    Sun M; Cole AP; Lipsitz SL; Trinh QD
    JAMA Oncol; 2018 Jan; 4(1):128-129. PubMed ID: 29098266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are patterns of health behavior associated with cancer screening?
    Meissner HI; Yabroff KR; Dodd KW; Leader AE; Ballard-Barbash R; Berrigan D
    Am J Health Promot; 2009; 23(3):168-75. PubMed ID: 19149421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cancer screening].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Sobue T; Yamanaka H; Fukuda M; Maruyama M; Eguchi K; Ito K; Smith M; Milsted B
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):125-34. PubMed ID: 15675598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
    Nickson C; Smith MA; Feletto E; Velentzis LS; Broun K; Deij S; Grogan P; Hall M; He E; St John DJ; Lew JB; Procopio P; Simms KT; Worthington J; Mann GB; Canfell K
    Elife; 2023 Apr; 12():. PubMed ID: 37022767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inner-city breast and cervical cancer screening: a cooperative report.
    Ghazal M; Tetu-Mouradjian LM; Jones A; Block SH
    R I Med; 1993 Apr; 76(4):195-8. PubMed ID: 8513183
    [No Abstract]   [Full Text] [Related]  

  • 57. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vision for improved cancer screening in Nigeria.
    Ishola F; Omole O
    Lancet Glob Health; 2016 Jun; 4(6):e359-60. PubMed ID: 27198833
    [No Abstract]   [Full Text] [Related]  

  • 59. Breast, stomach and colorectal cancer screening in Korea.
    Lee WC
    J Med Screen; 2006; 13 Suppl 1():S20-2. PubMed ID: 17227637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Model program for the prevention and detection of gynecologic cancer in developing countries].
    Goes JS; Goes JC
    Bol Oficina Sanit Panam; 1980 Nov; 89(5):397-408. PubMed ID: 6452131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.